COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19. Kozak, Robert A | University of Toronto | Operating Grant | $44,460 CIHR Ontario 2021 Read More